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Abstract
Aims/hypothesis Apart from transcription factors, little is
known about the molecules that modulate the proliferation
and differentiation of pancreatic endocrine cells. The early
expression of tyrosine hydroxylase (TH) in a subset of gluca-
gon+ cells led us to investigate whether catecholamines have a
role in beta cell development.
Methods We studied the immunohistochemical characteristics
of TH-expressing cells in wild-type (Th+/+) mice during early
pancreas development, and analysed the endocrine pancreas
phenotype of TH-deficient (Th−/−) mice. We also studied the
effect of dopamine addition and TH-inhibition on insulin-
producing cells in explant cultures.
Results In the mouse pancreas at embryonic day (E)12.5–
E13.5, the ∼10% of early glucagon+ cells that co-expressed
TH rarely proliferated and did not express the precursor mark-
er neurogenin 3 at E13.5. The number of insulin+ cells in the
Th−/− embryonic pancreas was decreased as compared with
wild-type embryos at E13.5. While no changes in pancreatic
and duodenal homeobox 1 (PDX1)+-progenitor cell number
were observed between groups at E12.5, the number of
neurogenin 3 and NK2 homeobox 2 (NKX2.2)-expressing
cells was reduced in Th−/− embryonic pancreas, an effect that
occurred in parallel with increased expression of the transcrip-
tional repressorHes1. The potential role of dopamine as a pro-
beta cell stimulus was tested by treating pancreas explants
with this catecholamine, which resulted in an increase in total
insulin content and insulin+ cells relative to control explants.
Conclusions/interpretation A non-neural catecholaminergic
pathway appears to modulate the pancreatic endocrine precur-
sor and insulin producing cell neogenesis. This finding may
have important implications for approaches seeking to pro-
mote the generation of beta cells to treat diabetes.
Keywords Beta cells . Catecholamines . Dopamine .
Glucagon . Insulin . Islet development . Neurogenin 3 .
Tyrosine hydroxylase
Abbreviations
E Embryonic day
NCC Neural crest cell
NGN3 Neurogenin 3
NKX2.2 NK2 homeobox 2
PDX1 Pancreatic and duodenal homeobox 1
PHOX2b Paired-like homeobox 2b
PTF1A Pancreas transcription factor 1 complex
SOX10 SRY (sex determining region Y)-box 10
Introduction
Studies of developmental biology have led to significant
advances in our understanding of the generation of insulin-
producing cells [1, 2]. However, further research is required to
unravel the molecular mechanisms that underlie the processes
of proliferation, differentiation and survival, which maintain
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the pool of pancreatic progenitor cells and lead to a mature
beta cell phenotype. These molecules include specific combi-
nations of well-characterised transcription factors [3, 4] and
less well known secreted signals [5–7]. In the present study,
we set out to investigate the putative role of the catecholamin-
ergic pathway in beta cell development.
Pancreas morphogenesis involves two overlapping phases.
The primary transition, from embryonic day (E) 8.5/9 to
E12.5, encompasses the specification of the pancreatic epithe-
lium by the expression of PDX1 and PTF1A [8–10], the
protrusion of the pancreatic epithelium into the surrounding
mesenchyme and the beginning of expansion and branching.
The secondary transition, from E13.5 to E15.5, involves mas-
sive differentiation of beta cells and continued expansion and
branching [11]. The initial stages of foregut endoderm pan-
creatic specification and epithelial expansion are strongly
influenced by signals from neighbouring tissues, including
the mesenchyme [5, 11, 12]. Growth factors known to influ-
ence early pancreatic cell decisions include fibroblast growth
factors, Wnt and TGFβ family members [5, 6].
At E12.5, the pancreatic epithelium in the mouse is com-
posed mainly of multipotent pancreatic progenitors that ex-
press PDX1 and some early differentiated endocrine cells
containing glucagon [13]. The PDX1+ progenitors are pro-
gressively committed to more restricted fates by the combina-
torial expression of several transcription factors [14]. The
activation of neurogenin 3 (NGN3) expression in these pre-
cursors triggers the specific gene regulatory networks that
define the endocrine programme [15, 16]. NGN3 plays an
essential role at this stage, as evidenced by the impaired
development of islets in NGN3-deficient mice [15]. Nkx2.2,
one of the genes involved in this cascade, acts downstream of
NGN3 and is required for initial beta cell differentiation and,
to a lesser extent, for the differentiation of other endocrine
cells [17]. Notch signalling also greatly influences the transi-
tion from a multipotent progenitor towards an endocrine pre-
cursor [18, 19]. HES1, a downstream effector of the Notch
pathway, represses the transcriptional activity of the Neurog3
gene (which encodes NGN3), thus preventing premature en-
docrine differentiation [20, 21].
In addition to the complex intrinsic network of pancreatic
transcription factors, extrinsic signals act as modulators of cell
progenitor generation and lineage or fate decisions [7, 11]. No
function has been ascribed to catecholamines in pancreatic
development, although the pioneering studies of Teitelman
and Lee [22] demonstrated the presence of a small subpopu-
lation of cells expressing tyrosine hydroxylase (TH), the first
enzyme of the catecholaminergic pathway, in the mouse pan-
creatic bud by E10. Catecholamines have recently been im-
plicated in adult neurogenesis [23] and embryonic
haematopoiesis [24]. Moreover, we have previously demon-
strated that TH is required for heart morphogenesis and car-
diomyocyte differentiation [25], broadening the spectrum of
neurohormonal effects of catecholamines to other functions in
development and differentiation. The aim of this study was to
investigate a possible novel role of catecholamines in pancre-
atic development.
Methods
Detailed methods, primer and probe sequences, and antibod-
ies used are provided in the electronic supplementary material
(ESM) Methods and ESM Tables 1–3. The sources of chem-
ical substances are provided in ESM Table 4.
Mice and embryos All procedures involving animals were
approved by the ethics committee of Centro de Investigaciones
Biológicas and were in accordance with the European Union
guidelines. The C57BL6/J TH heterozygote mouse strain was
kindly provided by R. D. Palmiter (University of Washington,
Seattle, WA, USA) [26], and was backcrossed with wild-type
CD1 mice for up to ten generations (for further details see the
ESM Methods).
Immunoblotting Pancreas samples of the indicated ages were
pooled, homogenised and analysed by immunoblotting using
standard procedures (for further details, see the ESM
Methods).
Pancreas explant cultures E13.5 dorsal pancreatic buds were
cultured on coverglasses coated with 25 mg/l collagen, in 24-
well plates containing 1 ml of DMEM with 10% (vol./vol.)
FBS, 1% (vol./vol.) penicillin/streptomycin and 1% (vol./vol.)
glutamine. Where indicated, the cultured mediumwas supple-
mented with 0.04 mmol/l dopamine or 1 mmol/l α-methyl-L-
tyrosine. Explants were cultured for up to 5 days (after 24 h of
stabilisation) at 37°C and 5% CO2, and the medium was
refreshed daily. For cell proliferation experiments, explants
were treated with 5 μmol/l BrdU. After culture, the explants
were processed for whole mount, tissue section or cytospin
(for further details, see the ESM Methods).
Immunohistochemistry and TUNEL E12.5 and E13.5 embry-
os were fixed overnight at 4°C with 4% (wt/vol.) PFA, em-
bedded in paraffin, immunostained and TUNEL analysed
using standard procedures (for further details, see the ESM
Methods).
RNA isolation and quantitative real-time PCR Total RNA
from pancreas was extracted using TRIzol Reagent, and
reverse transcription performed with random primers and
Superscript III enzyme (all from Life Technologies, Carls-
bad, CA, USA) according to the manufacturer’s instruc-
tions. Quantitative real-time PCR was performed in a 7900
HT-Fast real-time PCR (Life Technologies) system with
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Taqman Universal PCR Master Mix using Taqman assays
(Life Technologies) or probes from the Universal Probe
Library (Roche, Mannheim, Germany).
In vivo BrdU labelling Pregnant mothers were i.p. injected
with BrdU (100 mg/kg body weight) 2 h before sacrifice. For
details of BrdU detection and cell counting, see the ESM
Methods.
ELISA Catecholamines were determined by ELISA (for fur-
ther details, see the ESM Methods).
Images and statistical analysis Images were collected by
confocal microscopy (Leica TCS-SP5; Leica Microsystems,
Wetzlar, Germany). For morphometric analysis, quantification
of the total and epithelial pancreatic area was performed
in E-cadherin-stained sections using Image J 1.48v
(http://imagej.nih.gov/ij). The number of cells expressing a
specific marker was determined as described in the ESM
Methods.
Statistical analyses were performed using non-parametric
tests (Mann–Whitney U test) for non-normally distributed data
using GraphPad Prism 5, version 5.01 (www.graphpad.com).
Data from at least three independent experiments were analysed
in each case, with p values <0.05 considered significant.
Results
TH is expressed in a subset of early glucagon+ cells in the
developing mouse pancreas We first sought to better charac-
terise the early TH-expressing cell population. Pancreatic Th
mRNA was analysed in samples from E11.5 to E15.5, the
latter being the embryonic stage during which significant
sympathetic fibre innervation begins. Levels of Th mRNA
were similar during the primary transition (E11.5–12.5) and
the beginning of the secondary transition (E13.5–14.5), but
decreased significantly at E15.5 (Fig. 1a), coinciding with the
maximum expression of Neurog3 and around the peak of beta
cell differentiation. Immunoblotting of pancreas protein ex-
tracts revealed a 60 kDa band corresponding to TH (Fig. 1b).
The band specificity was confirmed by the absence of signal
in pancreatic extracts from TH-deficient embryos (ESM
Fig. 1). TH protein levels were similar up to E15.5. The
apparent discrepancy between the mRNA and protein profiles
for TH could be due, at least in part, to the contribution of the
sympathetic projections to the total content of TH protein.
Using co-immunofluorescence we further characterised the
population of TH-expressing cells. Glucagon-expressing cells
are one of the first pancreatic cells to differentiate. At E12.5
(Fig. 1c) and E13.5, most TH-expressing cells (∼90%) co-
expressed glucagon, although TH+ cells represented only a
small proportion (∼10%) of these early glucagon+ cells. At
Fig. 1 TH is expressed during early pancreas development in mice. (a)
Quantitative real-time PCR of three to five pooled embryonic pancreases
(E11.5 to E15.5). Levels of Th transcripts were normalised to 18S rRNA
levels and the data are presented on a logarithmic scale. Results represent
the mean±SEM of at least three different pools for each embryonic stage.
*p<0.05 vs E11.5. (b) TH immunoblot of protein extracts from four
pooled pancreases (E11.5 to E15.5). Adult adrenal gland (AG) extract
was included as a positive control andβ-actin as a loading control. As TH
is highly expressed in AG, only low amounts of AG protein were loaded,
so AG β-actin was not detected. The blot is representative of three
independent experiments. (c–g) Embryonic pancreatic sections. (c) Co-
immunostaining for PDX1 (green), TH-rabbit (red) and glucagon (GCG,
cyan). (d) Double immunostaining for E-cadherin (green) and TH-rabbit
(red). (e) Double-immunostaining for BrdU (green) and TH-rabbit (red).
Arrows indicate double-positive cells. (f) Double immunostaining for
βIII-tubulin (green) and TH-mouse (red). (g) Double-immunostaining
for neurofilament (NF, green) and TH-rabbit (red). White X indicates
blood cells. Scale bar, 50 μm
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later stages of development (E14.5 and E15.5), the degree of
co-expression tended to decrease (ESM Fig. 2a, b).
The TH+ cells shared features with the overall early gluca-
gon population: they showed little co-localisation with PDX1
[9, 19] (Fig. 1c); they localised in clusters within regions of the
pancreatic epithelium with low E-cadherin expression [27]
(Fig. 1d); and rarely incorporated the mitotic marker BrdU
(∼6%; Fig. 1e). These features are characteristics of hormone-
expressing differentiated cells. Furthermore, we observed no
co-expression of TH and the endocrine precursor marker
NGN3 at E13.5 (see below).
TH+ cells did not express βIII-tubulin or neurofilament
(neuronal markers) (Fig. 1f, g). They expressed neither SRY
(sex determining region Y)-box 10 (SOX10) nor paired-like
homeobox 2b (PHOX2b)—both neural crest cell [NCC]
markers (ESM Fig. 3a)—confirming their non-neural pheno-
type. Moreover, at later stages of development (E14.5–15.5)
when the first sympathetic projections (TH+ and βIII-
tubulin+) were detected, the TH+ cell bodies did not express
βIII-tubulin (ESM Fig. 2c, d). Taken together, these results
demonstrate the endocrine character of early TH+ cells.
Beta cell number is modulated by the catecholaminergic
pathway To date, no clear role has been ascribed to the early
glucagon+ cells. Indeed, it has been suggested that this cell
population disappears during development and does not mea-
surably contribute to the adult organ [28, 29]. To assess the
role of TH in a subpopulation of the early glucagon+ cells
during pancreas development we phenotypically characterised
the pancreas of TH-deficient mice. As embryonic lethality
begins to occur from E12.5 in Th−/− embryos [26], we studied
E13.5 embryos, the latest embryonic stage at which a signif-
icant number of live Th−/− embryos can be collected. Mor-
phometric analysis of the E12.5 and 13.5 pancreatic primordia
by E-cadherin immunostaining revealed no significant differ-
ences in either the epithelial area or total (epithelium+mesen-
chyme) pancreatic area between Th+/+ and Th−/− embryos
(data not shown). At the beginning of the secondary transition,
insulin-expressing cells begin to accumulate and the popula-
tion increases exponentially until E15.5. We investigated
whether the emerging population of insulin-expressing cells
was affected by the absence of TH expression. The number of
insulin+ cells in the whole pancreas of E13.5 Th−/− embryos
was decreased relative to that in the whole pancreas of Th+/+
embryos. By contrast, we observed no differences between
genotypes in the number of glucagon+ cells (Fig. 2a–c).
Quantitative real-time PCR analysis confirmed lower expres-
sion levels of both insulin genes (Ins1 and Ins2) in the E13.5
Th−/− pancreatic primordium, without changes in GcgmRNA
levels (Fig. 2d–f).
To confirm the impact of TH deficiency on the final num-
ber of insulin-expressing cells, we established an organotypic
pancreas culture in which the mesenchyme was preserved.
Beginning at E13.5, after 24 h of stabilisation of the culture
(day 0), the pancreatic explants were cultured for 5 days. The
total number of insulin+ cells in the Th−/− explants at the end
of the culture period was decreased compared with that in the
Th+/+ explants (Fig. 3a, b).
Lineage studies have established that all endocrine cells are
derived from NGN3-expressing progenitors [16]. Further-
more, the number of NGN3+ precursors during embryonic
development determines the number of endocrine cells at birth
[30]. We therefore analysed the NGN3+ cell population. We
observed a decrease in the number of NGN3-expressing cells
in the E13.5 Th−/− vs Th+/+ pancreas (Fig. 4a, b). In agreement
with this finding, Neurog3mRNA levels in the pancreas were
lower in mutant embryos than in Th+/+ littermates (Fig. 4d).
NKX2.2 is a transcription factor required for the determina-
tion of beta cell fate [17], and its expression is regulated by
NGN3 [31]. We found that the number of cells expressing
NKX2.2 in the Th−/− pancreas was decreased compared with
Fig. 2 The number of insulin-expressing cells is decreased in the pan-
creas of TH-deficient E13.5 embryos. (a) Double immunostaining for
insulin (INS, cyan) and glucagon (GCG, red). Nuclei are stained with
DAPI. Arrows andwhite X indicate insulin+ and blood cells, respectively.
Scale bar, 50 μm. (b, c) Quantification of the total number of insulin- and
glucagon-expressing cells in whole pancreas. (d–f) Quantitative real-time
PCR of individual pancreases. Levels of the Ins1, Ins2 and Gcg
transcripts were normalised to 18S rRNA and Th+/+ values were set
at 1. Results represent the mean ± SEM of at least five animals.*p<0.05
vs Th+/+
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that in the Th+/+ littermates (Fig. 4a, c). A similar trend was
observed for Nkx2.2 mRNA levels, although the differences
between the Th+/+ and Th−/− groups did not reach statistical
significance (Fig. 4e).
The pancreatic phenotype of TH-deficient mice involves an
increase in Hes1 expression before secondary transition We
investigated whether the decrease in the number of NGN3+
endocrine precursors resulted from depletion of the pancreatic
progenitor pool. Immunostaining with the progenitor marker
PDX1 revealed comparable pancreatic progenitor populations
in wild-type and TH-deficient embryos (Fig. 5a). This finding
is in agreement with the absence of changes seen in the E-
cadherin+ epithelial area (data not shown). Moreover, the
pancreatic epithelium proliferation rate, as measured using
the mitotic marker phospho-histone H3 (pHH3), was similar
in both genotypes (Fig. 5b), and we observed no differences in
the cell death rate, as measured by TUNEL-staining (Fig. 5c).
These results rule out the possibility that alterations in either
the rate of pancreatic epithelial proliferation or of cell death
mediate the observed decrease in the number of NGN3+
precursors. We next focused on the Notch signalling pathway,
which negatively regulates Neurog3 expression through the
transcriptional repressor HES1 [20]. As Neurog3 gene activa-
tion requires the release of HES1-mediated repression, we
analysed Hes1 mRNA expression levels and found them
significantly higher in the Th−/− vs Th+/+ pancreas (Fig. 5d).
Insulin-expressing cells in pancreas explants are increased by
dopamine treatment and decreased by TH inhibition
Characterisation of the TH-deficient pancreas revealed that
catecholamines are important modulators of endocrine and
beta cell differentiation. Indeed, analysis of catecholamine
content by ELISA confirmed the presence of dopamine
(289 fg/pancreas) and noradrenaline (norepinephrine;
652 fg/pancreas) in the E13.5 pancreatic primordium
in vivo, as well as in E13.5 explants cultured for 24 h
(dopamine, 87.3 fg/explant; noradrenaline, 290 fg/explant).
We next investigated the pro-beta cell potential of catechol-
amines in vitro, treating pancreas explants with dopamine (the
initial catecholamine of the pathway). We had previously
confirmed the presence of dopamine receptors by quantitative
real-time PCR. All five receptors tested were present by E11.5
and were expressed with distinct developmental profiles
(ESM Fig. 4). Beginning at E13.5 (day 0), explants were
treated daily for 5 days with dopamine. The total number of
insulin+ cells was higher in dopamine-treated vs untreated
explants (Fig. 6a, b) but, in agreement with our in vivo obser-
vations, we detected no change in the total number of
glucagon-expressing cells (Fig. 6a, c). The proliferation rate
at 2 days post culture, as measured by BrdU incorporation,
was unaffected by dopamine treatment (data not shown), but
decreased after 5 days of culture (Fig. 6d). Furthermore,
Fig. 3 Decreased number of insulin-expressing cells in the TH-deficient
pancreatic explants. (a) Immunostaining for insulin (INS, cyan) in E13.5
pancreatic explants cultured for 5 days. Nuclei are stained with DAPI.
Scale bar, 100 μm. (b) Quantification of total number of insulin-
expressing cells. Results represent the mean ± SEM of at least four
explants per genotype. *p<0.05 vs Th+/+
Fig. 4 The endocrine precursor cell population is reduced in the pancreas
of E13.5 TH-deficient embryos. (a) Double immunostaining for NKX2.2
(green), NGN3 (green) and TH-rabbit (red). Nuclei are stained with
DAPI. White X indicates blood cells. The insets correspond to magnifi-
cation of representative cells. Scale bar, 50 μm. (b, c) Quantification of
the total number of NGN3- and NKX2.2-expressing cells in whole
pancreas. (d, e) Quantitative real-time PCR of individual pancreases.
Levels of Neurog3 and Nkx2.2 transcripts were normalised to 18S rRNA
and Th+/+ values were set at 1. Results represent the mean ± SEM of at
least five embryos.* p<0.05, ** p<0.01 vs Th+/+
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analysis of the double-labelled insulin/BrdU cells showed that
dopamine did not affect the extremely low proliferation rate of
the differentiated insulin+ cells (data not shown).
In contrast to the pro-beta cell effect of dopamine, chal-
lenging pancreatic explants for 1 day with an inhibitor of TH
(α-methyl-L-tyrosine) decreased their insulin content relative
to that in the controls (ESM Fig. 5a, b).
Discussion
The postnatal number of pancreatic islet cells depends on the
size of the progenitor population, its rate of differentiation and
the rates of proliferation and cell death of progenitors/
precursors and mature endocrine cells. Here, we show that
TH expression in the developing pancreas is required to
generate the necessary number of endocrine NGN3+ precur-
sors and insulin+ cells via a mechanism involving changes in
the expression of the transcription factor Hes1.
We confirm and build upon previously published findings
[22, 32–34] demonstrating TH expression in a small subpop-
ulation of early glucagon+ cells, which appear as early as E9.5
in the mouse pancreatic bud. Early glucagon+ cells form a
distinctive endocrine cell pool that does not express the com-
plement of markers typical of mature glucagon-secreting cells
[35]. Our results indicate that TH expression is another dis-
tinct feature of a discrete subpopulation of these heteroge-
neous early glucagon+ cells.
Transient catecholamine biosynthetic enzyme expression
has been described in a number of embryonic neuronal sub-
populations during development [36, 37], including cells
found in the stomach and duodenum [36] that express both
TH and neurofilament proteins. However, the pancreatic early
catecholaminergic cells described here are, to the best of our
knowledge, the only embryonic cell type with a non-neuronal
endocrine phenotype, as evidenced by the lack ofβIII-tubulin,
neurofilament, SOX10 or PHOX2B expression. Interestingly,
we observed a certain degree of overlap between some of the
transcription factors involved in alpha cell specification and
subsequent glucagon expression, and the set of transcription
factors active in catecholaminergic neurons, i.e. aristaless-
Fig. 5 Hes1 expression is increased in the pancreas of TH-deficient
embryos. Quantification of the number of (a) PDX1- or (b)
phospho-histone H3 (pHH3)-expressing cells in sections of E12.5 pan-
creas. Results represent the mean ± SEM of five whole pancreases for
each genotype. (c) Quantification of the number of TUNEL+ cells in the
pancreatic epithelial area at E13.5. Results represent the mean ± SEM of
three whole pancreases for each genotype. (d) Quantitative real-time PCR
of individual pancreases of E12.5 embryos. The levels of Hes1 transcript
were normalised to 18S rRNA and Th+/+ values were set at 1. Results
represent the mean ± SEM of at least seven pancreases per genotype.
*p<0.05 vs Th+/+
Fig. 6 Dopamine administration increases the number of insulin-
expressing cells in pancreatic explants. (a) Double immunostaining for
insulin (INS, cyan) and glucagon (GCG, red) in explants cultured for
5 days. Nuclei are stained with DAPI. Scale bar, 100 μm. (b, c) Quanti-
fication of total number of insulin- and glucagon-expressing cells. Results
represent the mean ± SEM of five explants per condition. *p<0.05 vs
control (d) Quantification of the number of BrdU+ cells in cytospin of
explants cultured for 5 days. Results represent the mean ± SEM of at least
four explants per condition. *p<0.05 vs control
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related homeobox (ARX), forkhead box protein A1
(FOXA1), FOXA2 [38–40]. Significant parallels have been
described between the transcription factor networks involved
in the formation of beta cells and those found in serotonergic
neurons [41]. However, the molecular mediators of TH tran-
scriptional activation in the subpopulation of TH+/glucagon+
cells remains unknown.
We provide novel data on the functional significance of
the TH-catecholamine pathway during development. TH
expression, although restricted to a small proportion of
endocrine cells is crucial for the initiation (at E13.5) of
the massive wave of beta cell differentiation. At this stage,
the number of insulin+ cells in the Th−/− embryonic pancreas
was reduced and the relevance of this initial decrease is
supported by the lower number of insulin+ cells in the Th−/−
pancreatic explants after 5 days in culture. The observed
decrease in insulin+ cells at E13.5 was accompanied by a
decrease in the pool of endocrine precursors expressing
NGN3, and in the number of precursors expressing its down-
stream target gene Nkx2.2. NGN3 triggers the activation of a
set of transcription factors, including NKX2.2, that are
involved in driving the differentiation of insulin-producing
beta cells [42]. However, in Th−/− embryos the general pool
of PDX1+ pancreatic progenitors and the pancreatic epithelial
area were comparable with those in wild-type embryos, in
agreement with the absence of changes in proliferation and the
apoptotic index, suggesting that the TH deficiency affects beta
cell neogenesis.
Although it has been shown that NCCs exert an important
influence in beta cell differentiation [43], two observations
argue against an implication of NCCs in the TH-deficiency-
induced beta cell phenotype: (1) TH is not co-expressed with
either SOX10 or PHOX2B; (2) expression of Sox10 and
Phox2b is not affected by Th deletion (ESM Fig. 3).
No changes in the number of alpha cells (the other differ-
entiating endocrine cells found at the same developmental
time-point) were observed in E13.5 Th−/− embryos or in
pancreatic explants after 5 days of dopamine treatment. A
selective effect on beta cell differentiation has also been
described for retinoic acid [44]. It is unclear why the decrease
in the NGN3+ and NKX2.2+ progenitor pools observed in TH-
deficient mice does not affect the number of alpha cells. We
can only speculate that catecholamines play a more central
role in the triggering or maintenance of beta cell differentia-
tion than of alpha-cell differentiation, or in the induction of
distinct classes of NGN3+ progenitors that preferentially dif-
ferentiate into insulin cells.
It has been shown that the competence of the pancreatic
epithelium to generate the different endocrine cell types
upon NGN3 expression changes throughout development,
suggesting the existence of heterogeneous pools of pro-
genitors and/or different extrinsic cues during pancreas
organogenesis [45].
Given that TH expression promotes the beta cell differen-
tiation programme, as evidenced by the pancreatic phenotype
of the TH-deficient mouse, we studied the pro-beta cell effect
of catecholamines in vitro. Whereas inhibition of TH activity
in pancreatic explants decreased insulin levels, the exogenous
addition of dopamine increased the number of insulin-
producing cells without affecting the number of glucagon+
cells. This effect occurred in the absence of increased prolif-
eration.Moreover, pancreas cultured with dopamine exhibited
a lower proliferation rate at the end of the culture period. This
could be due to exhaustion of the progenitor pool as a result of
the activation of the differentiation programme.
Taking into consideration that both dopamine and nor-
adrenaline are present endogenously in the E13.5 pancreatic
primordium, and that dopamine and adrenergic receptors (data
not shown) are present in the embryonic pancreas, it is not
possible to conclude which catecholamine is the main player
mediating the pro-beta cell effect. In fact, dopamine added
exogenously could be converted into noradrenaline. Addition-
al studies are required to further explore these possibilities.
We next investigated the possible involvement of Notch
pathway in order to identify the mechanism at work upstream
of NGN3. During the initial steps of pancreas organogenesis,
Notch signalling is required to maintain an adequate progen-
itor pool, thus precluding premature differentiation. This is
achieved by the expression of the Notch effector Hes1, which
directly inhibits Neurog3 transcriptional activity; triggering of
the endocrine programme is dependent on the release of
Neurog3 from the inhibitory influence of HES1 [46]. In the
pancreas of Th−/− embryos, in contrast with Th+/+ mice, the
decrease in NGN3 expression was accompanied by an in-
crease in Hes1 expression, placing the catecholamine effect,
at least in part, at the level of Notch signalling regulation.
We did not find a decrease in Hes1 expression in E13.5
cultured pancreas explants after 1, 2 or 5 days of dopamine
treatment (data not shown). This apparent discrepancy be-
tween the in vivo and in vitro results could be due to the
different experimental conditions (with lack of additional
signals from the surrounding tissues in the case of the ex-
plants), or to the different developmental stages of Hes1
analysis—primary transition (E12.5) in vivo and secondary
transition (post E13.5) in cultured explants. We favour this
second possibility since recent studies propose that Notch
signalling may have two distinct roles in pancreas develop-
ment, depending on the stage: (1) an early role preventing
premature precursor differentiation and, later, (2) an effect on
lineage specification [47]. Nonetheless, our explant experi-
ments suggest that dopamine, after initiation of the secondary
transition, may be acting through an additional mechanism.
Catecholamines are molecules with well-described effects
on adult islet cell secretion and may be involved in islet cell
adaptation in insulin resistance [48]. The size of mature islets
and the number of insulin-producing cells they contain are
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critical determinants of pancreatic postnatal function and the
risk of developing diabetes [17, 49]. Therefore, our identifi-
cation of TH/catecholamines as modulators of the generation
of insulin-producing cells during development, or unravelling
in the future further actions of this pathway upon endocrine
maturation, may have important implications for strategies
aimed at regenerating or replacing beta cells in patients with
diabetes.
Importantly, the results presented here are consistent with
the paradigm whereby molecules that act as intercellular sig-
nalling mediators, with well-defined restricted roles in post-
natal organisms, are present at embryonic stages, during
which they participate in diverse functions often unrelated to
their later roles [50].
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